ArticleAlimentary pharmacology & therapeutics2022
Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues-treated patients with chronic hepatitis B - author's reply.
Eiichi OgawaPubMed ↗Publisher ↗
No numbers read from the abstract.